Mixed
In pediatric patients with Nonalcoholic Steatohepatitis (NASH), gut microbiota enriched in alcohol-producing bacteria (specifically Escherichia) leads to elevated endogenous blood ethanol levels, which drives oxidative stress and liver inflammation.
For individuals with NASH, standard weight loss advice may be insufficient if gut dysbiosis persists. This research suggests that targeting the gut microbiome (e.g., reducing alcohol-producing bacteria like E. coli) might be a necessary step to reduce liver inflammation, as endogenous alcohol production appears to drive the disease progression from obesity to NASH.
Our findings of increased abundance of Escherichia in NASH microbiomes, and of the elevated blood alcohol in NASH patients, together with the well-established role for alcohol metabolism in the generation of reactive oxygen species (ROS) and, consequently, liver inflammation, suggest a novel mechanism for the pathogenesis of NASH is: Gut microbiota enriched in alcohol-producing bacteria (e.g., E. coli) constantly produce more alcohol than healthy microbiota and therefore supply a constant source of ROS to the liver, which, in turn, causes liver inflammation.
Why this rating
Observational study in children; establishes correlation and biological plausibility but cannot prove causation in humans without intervention.
Source
Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASH
Lixin Zhu et al. · Hepatology · 2012
DOI 10.1002/hep.26093
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →